Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with an access-restricted message. This indicates an access issue rather than an update to the study record.SummaryDifference18%

- Check36 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, reflecting a software revision on the page with no changes to study content or user-facing details.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 indicating a minor site update to the page. This change does not modify study data, eligibility criteria, or the published details of the trial.SummaryDifference0.1%

- Check72 days agoChange DetectedVersion label on the study page was updated from v3.6.3 to v3.6.4, indicating a new revision of the record. This is an administrative update that does not modify the study content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now shows revision v3.6.3, replacing v3.6.2, indicating a small update to the page without altering the displayed study details.SummaryDifference0.1%

- Check100 days agoChange DetectedNew page revision v3.6.2 has been applied, replacing the previous v3.6.0. This appears to be a maintenance update that does not modify the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.